The treatment with ursodeoxycholic acid in elderly patients affected by NAFLD and metabolic syndrome: a case-control study.

@article{Troisi2013TheTW,
  title={The treatment with ursodeoxycholic acid in elderly patients affected by NAFLD and metabolic syndrome: a case-control study.},
  author={Giovanni Troisi and F Crisciotti and Vincenzo Gianturco and Elisa D'Ottavio and Cristina Lo Iacono and Valeria Formosa and Sciaila Bernardini and Alessia Bellomo and Benedetta Marigliano and Vincenzo Marigliano},
  journal={La Clinica terapeutica},
  year={2013},
  volume={164 3},
  pages={
          203-7
        }
}
AIMS Evaluating the prevalence and the degree of steatosis in geriatric patients (65 to 85 years of age) with Metabolic Syndrome (defined by ATP III criteria); searching for metabolic factors which are predictive for the degree of steatosis; evaluating the efficacy of Ursodeoxycholic Acid (UDCA) for 6 months in the treatment of patients with NAFLD or NASH. MATERIALS AND METHODS We studied 87 geriatric patients with Metabolic Syndrome. Steatosis was diagnosed and graded by laboratory… CONTINUE READING
BETA